这是一篇来自已证抗体库的有关人类 CCR6的综述,是根据56篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CCR6 抗体。
CCR6 同义词: BN-1; C-C CKR-6; CC-CKR-6; CCR-6; CD196; CKR-L3; CKRL3; CMKBR6; DCR2; DRY6; GPR29; GPRCY4; STRL22

BioLegend
小鼠 单克隆(G034E3)
  • 流式细胞仪; 人类; 图 3c
BioLegend CCR6抗体(Biolegend, G034E3)被用于被用于流式细胞仪在人类样本上 (图 3c). Front Immunol (2019) ncbi
小鼠 单克隆(G034E3)
  • 流式细胞仪; 人类; 图 s3
BioLegend CCR6抗体(BioLegend, G034E3)被用于被用于流式细胞仪在人类样本上 (图 s3). Eur J Immunol (2019) ncbi
小鼠 单克隆(G034E3)
  • 流式细胞仪; 人类; 图 1f
BioLegend CCR6抗体(BioLegend, 353408)被用于被用于流式细胞仪在人类样本上 (图 1f). Cell (2019) ncbi
小鼠 单克隆(G034E3)
  • 流式细胞仪; 人类; 图 3e
BioLegend CCR6抗体(BioLegend, G034E3)被用于被用于流式细胞仪在人类样本上 (图 3e). Front Immunol (2018) ncbi
小鼠 单克隆(G034E3)
  • 流式细胞仪; 人类; 图 2d
BioLegend CCR6抗体(Biolegend, G034E3)被用于被用于流式细胞仪在人类样本上 (图 2d). Ann Rheum Dis (2018) ncbi
小鼠 单克隆(G034E3)
  • 免疫组化-石蜡切片; 人类; 图 7
  • 流式细胞仪; 人类; 图 3a
BioLegend CCR6抗体(BioLegend, G034E3)被用于被用于免疫组化-石蜡切片在人类样本上 (图 7) 和 被用于流式细胞仪在人类样本上 (图 3a). PLoS ONE (2017) ncbi
小鼠 单克隆(G034E3)
  • 流式细胞仪; 人类; 图 s1
BioLegend CCR6抗体(BioLegend, G034E3)被用于被用于流式细胞仪在人类样本上 (图 s1). Oncoimmunology (2017) ncbi
小鼠 单克隆(G034E3)
  • 流式细胞仪; 人类; 图 s3c
BioLegend CCR6抗体(BioLegend, G034E3)被用于被用于流式细胞仪在人类样本上 (图 s3c). J Clin Invest (2017) ncbi
小鼠 单克隆(G034E3)
  • 流式细胞仪; 人类; 图 1c
BioLegend CCR6抗体(Biolegend, 353412)被用于被用于流式细胞仪在人类样本上 (图 1c). Sci Rep (2017) ncbi
小鼠 单克隆(G034E3)
  • 流式细胞仪; 人类; 图 3b
BioLegend CCR6抗体(BioLegend, G034E3)被用于被用于流式细胞仪在人类样本上 (图 3b). J Immunol (2017) ncbi
小鼠 单克隆(G034E3)
  • 流式细胞仪; 人类; 图 4a
BioLegend CCR6抗体(Biolegend, G034E3)被用于被用于流式细胞仪在人类样本上 (图 4a). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(G034E3)
  • 流式细胞仪; 人类; 表 1
BioLegend CCR6抗体(Biolegend, G034E3)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry A (2017) ncbi
小鼠 单克隆(G034E3)
  • 流式细胞仪; 人类; 图 3a
BioLegend CCR6抗体(Biolegend, G034E3)被用于被用于流式细胞仪在人类样本上 (图 3a). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(G034E3)
  • 流式细胞仪; 猕猴
BioLegend CCR6抗体(BioLegend, 353410)被用于被用于流式细胞仪在猕猴样本上. Nat Med (2016) ncbi
小鼠 单克隆(G034E3)
  • 流式细胞仪; 人类; 表 1
BioLegend CCR6抗体(BioLegend, G034E3)被用于被用于流式细胞仪在人类样本上 (表 1). J Immunol (2016) ncbi
小鼠 单克隆(G034E3)
  • 流式细胞仪; 人类; 图 5a
BioLegend CCR6抗体(BioLegend, 353418)被用于被用于流式细胞仪在人类样本上 (图 5a). Haematologica (2016) ncbi
小鼠 单克隆(G034E3)
  • 流式细胞仪; 人类; 图 1
BioLegend CCR6抗体(Biolegend, G034E3)被用于被用于流式细胞仪在人类样本上 (图 1). Oncoimmunology (2016) ncbi
小鼠 单克隆(G034E3)
  • 流式细胞仪; 人类; 图 4a
BioLegend CCR6抗体(biolegend, G034E3)被用于被用于流式细胞仪在人类样本上 (图 4a). J Immunol (2016) ncbi
小鼠 单克隆(G034E3)
  • 流式细胞仪; 人类; 图 2
BioLegend CCR6抗体(BioLegend, G034E3)被用于被用于流式细胞仪在人类样本上 (图 2). J Autoimmun (2015) ncbi
小鼠 单克隆(G034E3)
  • 流式细胞仪; 人类
BioLegend CCR6抗体(Biolegend, G034E3)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (2014) ncbi
赛默飞世尔
小鼠 单克隆(R6H1)
  • 流式细胞仪; 人类; 图 3a
赛默飞世尔 CCR6抗体(eBioscience, R6H1)被用于被用于流式细胞仪在人类样本上 (图 3a). J Virol (2017) ncbi
小鼠 单克隆(R6H1)
  • 免疫印迹; 人类; 图 5a
赛默飞世尔 CCR6抗体(eBioscience, 14-1969-82)被用于被用于免疫印迹在人类样本上 (图 5a). PLoS Genet (2016) ncbi
小鼠 单克隆(R6H1)
  • 流式细胞仪; 人类
赛默飞世尔 CCR6抗体(eBioscience, R6H1)被用于被用于流式细胞仪在人类样本上. Clin Immunol (2015) ncbi
小鼠 单克隆(R6H1)
  • 免疫印迹; 人类
赛默飞世尔 CCR6抗体(eBioscience, 14-1969)被用于被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(R6H1)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CCR6抗体(eBioscience, R6H1)被用于被用于流式细胞仪在人类样本上 (表 1). Nat Immunol (2014) ncbi
小鼠 单克隆(R6H1)
  • 免疫印迹; 大鼠
赛默飞世尔 CCR6抗体(eBioscience, R6H1)被用于被用于免疫印迹在大鼠样本上. Ann Rheum Dis (2014) ncbi
Novus Biologicals
大鼠 单克隆(18B9E6)
  • 免疫印迹; 小鼠; 图 6c
Novus Biologicals CCR6抗体(Novus Biologicals, NBP2-25220)被用于被用于免疫印迹在小鼠样本上 (图 6c). J Biol Chem (2017) ncbi
大鼠 单克隆(18B9E6)
  • 免疫组化-石蜡切片; African green monkey; 2.5 ug/ml; 图 2b
Novus Biologicals CCR6抗体(Novus Biologicals, 18B9E6)被用于被用于免疫组化-石蜡切片在African green monkey样本上浓度为2.5 ug/ml (图 2b). J Immunol (2017) ncbi
安迪生物R&D
小鼠 单克隆(53103)
  • 流式细胞仪; 人类; 图 4
安迪生物R&D CCR6抗体(R&D Systems, 53103)被用于被用于流式细胞仪在人类样本上 (图 4). J Allergy Clin Immunol (2018) ncbi
Enzo Life Sciences
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 1g
Enzo Life Sciences CCR6抗体(Enzo, adi-aap-371-e)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1g). EMBO J (2019) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 4e
Enzo Life Sciences CCR6抗体(Enzo Life Sciences, ADI-AAP-371-E)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 4e). J Clin Invest (2016) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 多克隆
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司 CCR6抗体(Abcam, ab137369)被用于被用于免疫印迹在人类样本上. Oncotarget (2016) ncbi
碧迪BD
人类 单克隆(11A9)
  • 流式细胞仪; 人类; 图 s3b
碧迪BD CCR6抗体(BD Biosciences, 565925)被用于被用于流式细胞仪在人类样本上 (图 s3b). Cell (2020) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 人类; 表 1
碧迪BD CCR6抗体(BD Biosciences, 563922)被用于被用于流式细胞仪在人类样本上 (表 1). J Clin Invest (2018) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 人类; 图 5a
碧迪BD CCR6抗体(BD Biosciences, 11A9)被用于被用于流式细胞仪在人类样本上 (图 5a). PLoS ONE (2017) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 人类; 图 7b
碧迪BD CCR6抗体(BD Pharmingen, 11A9)被用于被用于流式细胞仪在人类样本上 (图 7b). elife (2017) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 人类; 图 1
碧迪BD CCR6抗体(BD Biosciences, 559562)被用于被用于流式细胞仪在人类样本上 (图 1). J Cell Physiol (2017) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 人类; 表 3
碧迪BD CCR6抗体(BD Pharmingen, 11A9)被用于被用于流式细胞仪在人类样本上 (表 3). Am J Pathol (2017) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; African green monkey; 图 1a
  • 流式细胞仪; 人类; 图 3a
  • 流式细胞仪; 小鼠; 图 5a
碧迪BD CCR6抗体(BD Pharmingen, 11A9)被用于被用于流式细胞仪在African green monkey样本上 (图 1a), 被用于流式细胞仪在人类样本上 (图 3a) 和 被用于流式细胞仪在小鼠样本上 (图 5a). J Immunol (2017) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 猕猴; 图 2
碧迪BD CCR6抗体(BD Pharmingen, 560619)被用于被用于流式细胞仪在猕猴样本上 (图 2). Science (2016) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 人类; 图 5d
碧迪BD CCR6抗体(BD Biosciences, 11A9)被用于被用于流式细胞仪在人类样本上 (图 5d). J Immunol (2016) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; African green monkey; 图 s1
碧迪BD CCR6抗体(BD, 11A9)被用于被用于流式细胞仪在African green monkey样本上 (图 s1). J Med Primatol (2016) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 人类; 图 s3a
碧迪BD CCR6抗体(BD Biosciences, 11A9)被用于被用于流式细胞仪在人类样本上 (图 s3a). Eur J Immunol (2016) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CCR6抗体(BD, 559562)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 小鼠; 图 s2a
碧迪BD CCR6抗体(BD PharMingen, 11A9)被用于被用于流式细胞仪在小鼠样本上 (图 s2a). J Immunol (2016) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 人类; 图 1d
碧迪BD CCR6抗体(BD, 11A9)被用于被用于流式细胞仪在人类样本上 (图 1d). PLoS Pathog (2016) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 人类; 图 1
碧迪BD CCR6抗体(BD Biosciences, 11A9)被用于被用于流式细胞仪在人类样本上 (图 1). Retrovirology (2015) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 人类; 图 s3
碧迪BD CCR6抗体(BD Biosciences, 11A9)被用于被用于流式细胞仪在人类样本上 (图 s3). Sci Transl Med (2015) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 人类; 图 1
碧迪BD CCR6抗体(BD Biosciences, 559562)被用于被用于流式细胞仪在人类样本上 (图 1). Retrovirology (2015) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 人类; 图 2f
碧迪BD CCR6抗体(BD, 551773)被用于被用于流式细胞仪在人类样本上 (图 2f). PLoS Pathog (2015) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 人类; 图 3c
碧迪BD CCR6抗体(BD Pharmingen, 11A9)被用于被用于流式细胞仪在人类样本上 (图 3c). Retrovirology (2015) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 人类
碧迪BD CCR6抗体(BD Biosciences, 11A9)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 人类
碧迪BD CCR6抗体(BD, 11A9)被用于被用于流式细胞仪在人类样本上. Eur J Immunol (2014) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 人类; 图 1
碧迪BD CCR6抗体(BD Bioscience, 11A9)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2014) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 人类
碧迪BD CCR6抗体(BD, 11A9)被用于被用于流式细胞仪在人类样本上. J Exp Med (2014) ncbi
小鼠 单克隆(11A9)
  • 免疫细胞化学; 人类
碧迪BD CCR6抗体(BD Biosciences, 11A9)被用于被用于免疫细胞化学在人类样本上. Eur J Immunol (2014) ncbi
小鼠 单克隆(11A9)
  • 流式细胞仪; 猕猴
碧迪BD CCR6抗体(BD Bioscience, 11A9)被用于被用于流式细胞仪在猕猴样本上. Clin Immunol (2014) ncbi
文章列表
  1. Lee J, Hall J, Kroehling L, Wu L, Najar T, Nguyen H, et al. Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease. Cell. 2020;180:79-91.e16 pubmed 出版商
  2. Gal H, Lysenko M, Stroganov S, Vadai E, Youssef S, Tzadikevitch Geffen K, et al. Molecular pathways of senescence regulate placental structure and function. EMBO J. 2019;38:e100849 pubmed 出版商
  3. Thauland T, Pellerin L, Ohgami R, Bacchetta R, Butte M. Case Study: Mechanism for Increased Follicular Helper T Cell Development in Activated PI3K Delta Syndrome. Front Immunol. 2019;10:753 pubmed 出版商
  4. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed 出版商
  5. Bacher P, Hohnstein T, Beerbaum E, Röcker M, Blango M, Kaufmann S, et al. Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans. Cell. 2019;: pubmed 出版商
  6. D Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M, et al. P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes. J Clin Invest. 2018;128:3490-3503 pubmed 出版商
  7. Provine N, Binder B, FitzPatrick M, Schuch A, Garner L, Williamson K, et al. Unique and Common Features of Innate-Like Human Vδ2+ γδT Cells and Mucosal-Associated Invariant T Cells. Front Immunol. 2018;9:756 pubmed 出版商
  8. Jeffery H, McDowell P, Lutz P, Wawman R, Roberts S, Bagnall C, et al. Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score. PLoS ONE. 2017;12:e0188649 pubmed 出版商
  9. Molnar C, Scherer A, Baraliakos X, de Hooge M, Micheroli R, Exer P, et al. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis. 2018;77:63-69 pubmed 出版商
  10. Hensel M, Peng T, Cheng A, De Rosa S, Wald A, Laing K, et al. Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells. J Virol. 2017;91: pubmed 出版商
  11. Chen J, Martindale J, Cramer C, Gorospe M, Atasoy U, Drew P, et al. The RNA-binding protein HuR contributes to neuroinflammation by promoting C-C chemokine receptor 6 (CCR6) expression on Th17 cells. J Biol Chem. 2017;292:14532-14543 pubmed 出版商
  12. Lu G, Zhang X, Shen L, Qiao Q, Li Y, Sun J, et al. CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy. PLoS ONE. 2017;12:e0178352 pubmed 出版商
  13. Lepore M, Kalinichenko A, Calogero S, Kumar P, Paleja B, Schmaler M, et al. Functionally diverse human T cells recognize non-microbial antigens presented by MR1. elife. 2017;6: pubmed 出版商
  14. Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586 pubmed 出版商
  15. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed 出版商
  16. Buskermolen J, Roffel S, Gibbs S. Stimulation of oral fibroblast chemokine receptors identifies CCR3 and CCR4 as potential wound healing targets. J Cell Physiol. 2017;232:2996-3005 pubmed 出版商
  17. Singh A, Subhi Y, Krogh Nielsen M, Falk M, Matzen S, Sellebjerg F, et al. Systemic frequencies of T helper 1 and T helper 17 cells in patients with age-related macular degeneration: A case-control study. Sci Rep. 2017;7:605 pubmed 出版商
  18. Szabo P, Goswami A, Mazzuca D, Kim K, O Gorman D, Hess D, et al. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. J Immunol. 2017;198:2805-2818 pubmed 出版商
  19. Sullivan A, Wang E, Farrell J, Whitaker P, Faulkner L, Peckham D, et al. ?-Lactam hypersensitivity involves expansion of circulating and skin-resident TH22 cells. J Allergy Clin Immunol. 2018;141:235-249.e8 pubmed 出版商
  20. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed 出版商
  21. Ryan P, Sumaria N, Holland C, Bradford C, Izotova N, Grandjean C, et al. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals. Proc Natl Acad Sci U S A. 2016;113:14378-14383 pubmed
  22. Cecchinato V, Bernasconi E, Speck R, Proietti M, Sauermann U, D Agostino G, et al. Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization. J Immunol. 2017;198:184-195 pubmed
  23. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed 出版商
  24. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  25. Byrareddy S, Arthos J, Cicala C, Villinger F, Ortiz K, Little D, et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy. Science. 2016;354:197-202 pubmed
  26. Li G, Cunin P, Wu D, Diogo D, Yang Y, Okada Y, et al. The Rheumatoid Arthritis Risk Variant CCR6DNP Regulates CCR6 via PARP-1. PLoS Genet. 2016;12:e1006292 pubmed 出版商
  27. Lesina M, Wörmann S, Morton J, Diakopoulos K, Korneeva O, Wimmer M, et al. RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis. J Clin Invest. 2016;126:2919-32 pubmed 出版商
  28. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed 出版商
  29. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed 出版商
  30. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed 出版商
  31. Yamashita K, Kawata K, Matsumiya H, Kamekura R, Jitsukawa S, Nagaya T, et al. Bob1 limits cellular frequency of T-follicular helper cells. Eur J Immunol. 2016;46:1361-70 pubmed 出版商
  32. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed 出版商
  33. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  34. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed 出版商
  35. Thibaudin M, Chaix M, Boidot R, Végran F, Derangère V, Limagne E, et al. Human ectonucleotidase-expressing CD25high Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions. Oncoimmunology. 2016;5:e1055444 pubmed
  36. Xiong Y, Ahmad S, Iwami D, Brinkman C, Bromberg J. T-bet Regulates Natural Regulatory T Cell Afferent Lymphatic Migration and Suppressive Function. J Immunol. 2016;196:2526-40 pubmed 出版商
  37. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed 出版商
  38. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed 出版商
  39. Ikeda S, Kitadate A, Ito M, Abe F, Nara M, Watanabe A, et al. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma. Oncotarget. 2016;7:13563-74 pubmed 出版商
  40. Cleret Buhot A, Zhang Y, Planas D, Goulet J, Monteiro P, Gosselin A, et al. Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach. Retrovirology. 2015;12:102 pubmed 出版商
  41. Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166 pubmed 出版商
  42. Heigele A, Joas S, Regensburger K, Kirchhoff F. Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levels. Retrovirology. 2015;12:86 pubmed 出版商
  43. McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C, et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914 pubmed 出版商
  44. Lee J, Jeong I, Joh J, Jung Y, Sim S, Choi B, et al. Differential expression of CD57 in antigen-reactive CD4+ T cells between active and latent tuberculosis infection. Clin Immunol. 2015;159:37-46 pubmed 出版商
  45. DaFonseca S, Niessl J, Pouvreau S, Wacleche V, Gosselin A, Cleret Buhot A, et al. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 2015;12:38 pubmed 出版商
  46. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed 出版商
  47. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed 出版商
  48. Kudernatsch R, Letsch A, Guerreiro M, Löbel M, Bauer S, Volk H, et al. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. Eur J Immunol. 2014;44:3532-42 pubmed 出版商
  49. Hu H, Eller M, Zafar S, Zhou Y, Gu M, Wei Z, et al. Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals. Proc Natl Acad Sci U S A. 2014;111:13439-44 pubmed 出版商
  50. Arlehamn C, Seumois G, Gerasimova A, Huang C, Fu Z, Yue X, et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol. 2014;193:2931-40 pubmed 出版商
  51. Longman R, Diehl G, Victorio D, Huh J, Galan C, Miraldi E, et al. CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014;211:1571-83 pubmed 出版商
  52. Liu J, Ke F, Xu Z, Liu Z, Zhang L, Yan S, et al. CCR6 is a prognostic marker for overall survival in patients with colorectal cancer, and its overexpression enhances metastasis in vivo. PLoS ONE. 2014;9:e101137 pubmed 出版商
  53. Gautron A, Dominguez Villar M, de Marcken M, Hafler D. Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells. Eur J Immunol. 2014;44:2703-2711 pubmed 出版商
  54. Demberg T, Mohanram V, Venzon D, Robert Guroff M. Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model. Clin Immunol. 2014;153:264-76 pubmed 出版商
  55. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed 出版商
  56. Melis L, Van Praet L, Pircher H, Venken K, Elewaut D. Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-? production by interaction with its soluble E-cadherin ligand in chronically inflamed joints. Ann Rheum Dis. 2014;73:1223-31 pubmed 出版商